Product/Composition:- | Avanafil tablets |
---|---|
Strength:- | 50 mg, 100 mg, 200 mg |
Form:- | Tablet |
Reference Brands:- | Stendra(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Avanafil inhibits phosphodiesterase type 5 (PDE5), increasing nitric oxide and blood flow to the penis. It provides rapid onset of action, usually within 15 minutes, with a duration up to 6 hours. Benefits include quick, effective treatment for erectile dysfunction, supporting spontaneous sexual activity and improved confidence.
Avanafil tablets, marketed as Stendra, are approved in the US by the FDA and in the EU via EMA for erectile dysfunction. Regulatory approval requires detailed dossiers including clinical trial data, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, FDA reviews clinical efficacy and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance is vital for timely approval, safe use, and global availability of avanafil tablets, supporting effective management of erectile dysfunction worldwide and enhancing patient confidence.